CLSK
Price
$6.89Alerts
Change
+$0.32 (+4.87%)
Updated
Nov 11, 04:39 PM (EDT)
Capitalization
1.58B
13 days until earnings call
Intraday BUY SELL Signals
PHR
Price
$12.77Alerts
Change
-$0.36 (-2.74%)
Updated
Nov 11, 03:26 PM (EDT)
Capitalization
783.34M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLSK vs PHR

CLSK vs PHR Comparison Chart in %
View a ticker or compare two or three
VS
CLSK vs. PHR commentary
Nov 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSK is a Hold and PHR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CLSK with price predictions
Nov 10, 2026

CLSK in upward trend: price may jump up because it broke its lower Bollinger Band on November 04, 2026

CLSK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 29 cases where CLSK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CLSK's RSI Oscillator exited the oversold zone, 24 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 64 cases where CLSK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

Following a +21.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLSK advanced for three days, in 226 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CLSK turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 38 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

The 10-day moving average for CLSK crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

The 50-day moving average for CLSK moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLSK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for CLSK entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.078) is normal, around the industry mean (3.120). P/E Ratio (-1.630) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. P/S Ratio (5.397) is also within normal values, averaging (16.899).

The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. CLSK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLSK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
a Summary for PHR with price predictions
Nov 10, 2026

PHR in upward trend: 10-day moving average moved above 50-day moving average on October 21, 2026

The 10-day moving average for PHR crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on PHR as a result. In 68 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

PHR moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for PHR moved above the 200-day moving average on October 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +4.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where PHR advanced for three days, in 217 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

The Aroon Indicator entered an Uptrend today. In 107 of 132 cases where PHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.

Bearish Trend Analysis

The 10-day RSI Indicator for PHR moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 21 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 52 of 62 cases where PHR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

PHR broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. PHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.107) is normal, around the industry mean (4.477). PHR has a moderately high P/E Ratio (70.111) as compared to the industry average of (13.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.270) is also within normal values, averaging (6.065).

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

FUNDAMENTALS RATINGS
CLSK vs PHR: Fundamental Ratings
CLSK
PHR
OUTLOOK RATING
1..100
985
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9887
PRICE GROWTH RATING
1..100
8842
P/E GROWTH RATING
1..100
9895
SEASONALITY SCORE
1..100
5049

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLSK's Valuation (65) in the null industry is in the same range as PHR (88). This means that CLSK’s stock grew similarly to PHR’s over the last 12 months.

CLSK's Profit vs Risk Rating (100) in the null industry is in the same range as PHR (100). This means that CLSK’s stock grew similarly to PHR’s over the last 12 months.

PHR's SMR Rating (87) in the null industry is in the same range as CLSK (98). This means that PHR’s stock grew similarly to CLSK’s over the last 12 months.

PHR's Price Growth Rating (42) in the null industry is somewhat better than the same rating for CLSK (88). This means that PHR’s stock grew somewhat faster than CLSK’s over the last 12 months.

PHR's P/E Growth Rating (95) in the null industry is in the same range as CLSK (98). This means that PHR’s stock grew similarly to CLSK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLSKPHR
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
COMPARISON
Comparison
Nov 11, 2026
Stock price -- (CLSK: $6.57 vs. PHR: $13.13)
Brand notoriety: CLSK and PHR are both not notable
CLSK represents the Investment Banks/Brokers, while PHR is part of the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: CLSK: 86% vs. PHR: 76%
Market capitalization -- CLSK: $1.58B vs. PHR: $783.34M
CLSK [@Investment Banks/Brokers] is valued at $1.58B. PHR’s [@Services to the Health Industry] market capitalization is $783.34M. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $590 to $284.96B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.18B. The average market capitalization across the [@Investment Banks/Brokers] industry is $11.48B. The average market capitalization across the [@Services to the Health Industry] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLSK’s FA Score shows that 0 FA rating(s) are green while PHR’s FA Score has 0 green FA rating(s).

  • CLSK’s FA Score: 0 green, 5 red.
  • PHR’s FA Score: 0 green, 5 red.
According to our system of comparison, PHR is a better buy in the long-term than CLSK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLSK’s TA Score shows that 4 TA indicator(s) are bullish while PHR’s TA Score has 6 bullish TA indicator(s).

  • CLSK’s TA Score: 4 bullish, 5 bearish.
  • PHR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PHR is a better buy in the short-term than CLSK.

Price Growth

CLSK (@Investment Banks/Brokers) experienced а -19.39% price change this week, while PHR (@Services to the Health Industry) price change was +7.36% for the same time period.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -3.41%. For the same industry, the average monthly price growth was -18.34%, and the average quarterly price growth was -22.88%.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.67%. For the same industry, the average monthly price growth was +2.59%, and the average quarterly price growth was +28.54%.

Reported Earning Dates

CLSK is expected to report earnings on Nov 24, 2026.

PHR is expected to report earnings on Dec 02, 2026.

Industries' Descriptions

@Investment Banks/Brokers (-3.41% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

@Services to the Health Industry (+0.67% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
Interact to see
Advertisement

PHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHR has been loosely correlated with COIN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PHR jumps, then COIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHR
1D Price
Change %
PHR100%
+1.78%
COIN - PHR
57%
Loosely correlated
-2.92%
CLSK - PHR
55%
Loosely correlated
-4.92%
QTWO - PHR
49%
Loosely correlated
+1.47%
QLYS - PHR
49%
Loosely correlated
-13.51%
RIOT - PHR
49%
Loosely correlated
+2.38%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSNC78.820.93
+1.19%
SS&C Technologies Holdings
TKLF1.45N/A
N/A
Tokyo Lifestyle Co Ltd
SLRC11.79-0.05
-0.42%
SLR Investment Corp
KBH50.47-1.54
-2.96%
KB Home
NERV2.49-0.14
-5.32%
Minerva Neurosciences